H. Samyn

Reduction of HDL levels lowers plasma PLTP and affects its distribution among lipoproteins in mice.

T. van Gent, M. Moerland, R. van Haperen, 2009, Biochimica et biophysica acta.

Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolism.

F. Grosveld, T. van Gent, M. Moerland, 2009, Biochimica et biophysica acta.

Elevated Expression of Phospholipid Transfer Protein in Bone Marrow Derived Cells Causes Atherosclerosis

F. Grosveld, T. van Gent, M. Moerland, 2008, PloS one.

Acute Elevation of Plasma PLTP Activity Strongly Increases Pre-existing Atherosclerosis

F. Grosveld, T. van Gent, M. Moerland, 2008, Arteriosclerosis, thrombosis, and vascular biology.

Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic mice Published, JLR Papers in Press, August 29, 2007.

F. Grosveld, M. Jauhiainen, J. Metso, 2007, Journal of Lipid Research.

Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice.

F. Grosveld, T. van Gent, M. Moerland, 2009, Atherosclerosis.

Inducible expression of phospholipid transfer protein (PLTP) in transgenic mice: acute effects of PLTP on lipoprotein metabolism

J. Strouboulis, F. Grosveld, M. Moerland, 2007, Transgenic Research.

Inhibiting cyclin-dependent kinase/cyclin activity for the treatment of cancer and cardiovascular disease.

V. Andrés, S. Sanz-González, C. Castro, 2003, Current Pharmaceutical Biotechnology.

Abstract 1199: Elevated Macrophage Expression of Phospholipid Transfer Protein Causes Atherosclerosis

F. Grosveld, M. Moerland, A. Tol, 2006 .